Dana-Farber wanted to keep going with phase 1. As frustrating as it may be that we still haven't reached maximum tolerated dose, they obviously know a lot more than we do about what's going on. If the experts say keep going, they must have a good reason.
What about a cover story on Science about Kevetrin? What if going for a few more months gets that for us -- and also, absolute utter irrefutable proof that it works? Sorry for the patients who need it ASAP but in the long run, better for humanity.....
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links